UMass Lowell will resume on-campus instruction, research and campus life for Fall 2020. View the plan for more info.
In line with the center mission and UMass Lowell mission, CMINDS has a strong active collaborative research at a national and international level via active participation to a national and international project lead by the US FDA, and to increase the visibility of the CMINDS center research and UMass Lowell nationally and internationally. The international collaborative project and the international group involves six FDA (Food and Drug Administration) Centers, major biotechnology companies, National Institutes of Health (NIH), Environmental Protection Agency (EPA), National Institute of Standards and Technology (NIST), national and international academic laboratories, and other stakeholders. This international collaborative research group effort is centered on the development and evaluation of genomics RNA-seq and micro-arrays biomarkers for personalized medicine. This large effort involves approximately 161 federal agencies and national and international organizations, 200 research scientist/engineer/clinician participants from 10 countries, including individual scientists/engineers/clinicians from government, academia and private.